A critical advance in cancer study is occurring with the use of nanobodies to re-engage dysfunctional p53. This crucial cancer inhibitor protein is frequently inactivated in many types of tumors, causing uncontrolled https://getsocialselling.com/story7484890/nanobodies-reactivate-p53-a-promising-approach-for-malignant-treatment